Adma Biologics | ADMA - Net Income

Stock Price
16.61
Daily Change
-0.92 -5.22%
Monthly
-7.90%
Yearly
-1.57%
Q1 Forecast
16.77

Adma Biologics reported $36.43M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Adma Biologics USD 36.43M 2.21M Sep/2025
Alnylam Pharmaceuticals USD 251.08M 317.36M Sep/2025
Dynavax Technologies USD 18.72M 114.82M Jun/2025
Takeda JPY 103.64B 115.44B Dec/2025